Predictions
Kancera AB
Start price
Target price
Perf. (%)
€0.69
27.11.21
27.11.21
€1.00
27.11.22
27.11.22
-76.02%
28.11.22
28.11.22
Could be worthwhile Investment >10% per year
Onxeo S.A.
Start price
Target price
Perf. (%)
€0.41
27.11.21
27.11.21
€0.60
27.11.22
27.11.22
-56.65%
28.11.22
28.11.22
Could be worthwhile Investment >10% per year
Cidara Therapeutics Inc
Start price
Target price
Perf. (%)
€1.31
27.11.21
27.11.21
-
27.11.22
27.11.22
11.62%
12.12.21
12.12.21
Risky Investment
Sio Gene Therapies Inc.
Start price
Target price
Perf. (%)
€1.39
27.11.21
27.11.21
-
27.11.22
27.11.22
-12.10%
12.12.21
12.12.21
Risky Investment
JinkoSolar Holding Co. Ltd. ADR
Start price
Target price
Perf. (%)
€47.36
27.11.21
27.11.21
€60.00
27.11.22
27.11.22
-13.89%
11.12.21
11.12.21
ROE higher than 15% per year
Very valuable balance sheet
EBIT growth > 30% per year expected
Bad culture
Scanship Hldg ASA Nk -,10
Start price
Target price
Perf. (%)
€2.17
27.11.21
27.11.21
€2.00
27.11.22
27.11.22
6.08%
11.12.21
11.12.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Valneva SE
Start price
Target price
Perf. (%)
€28.30
27.11.21
27.11.21
€28.00
27.11.22
27.11.22
-44.88%
30.03.22
30.03.22
Could be worthwhile Investment >10% per year
Very valuable balance sheet
Repligen Corp.
Start price
Target price
Perf. (%)
€264.10
27.11.21
27.11.21
€300.00
31.12.23
31.12.23
-46.31%
08.05.23
08.05.23
Could be worthwhile Investment >10% per year
Peloton Interactive Inc.
Start price
Target price
Perf. (%)
€41.75
27.11.21
27.11.21
€60.00
31.12.23
31.12.23
-77.35%
25.07.22
25.07.22
Could be worthwhile Investment >10% per year
Bruker Corp.
Start price
Target price
Perf. (%)
€75.50
27.11.21
27.11.21
€100.00
31.12.23
31.12.23
-5.30%
08.05.23
08.05.23
Could be worthwhile Investment >10% per year
Zoom Video Communications Inc
Start price
Target price
Perf. (%)
€201.45
27.11.21
27.11.21
€230.00
31.12.23
31.12.23
-71.40%
08.05.23
08.05.23
Could be worthwhile Investment >10% per year
Boeing Co.
Start price
Target price
Perf. (%)
€175.50
27.11.21
27.11.21
€150.00
31.12.23
31.12.23
-25.44%
28.06.22
28.06.22
Could be worthwhile Investment >10% per year
Snowflake Inc.
Start price
Target price
Perf. (%)
€321.15
27.11.21
27.11.21
€370.00
31.12.23
31.12.23
-56.34%
08.05.23
08.05.23
Could be worthwhile Investment >10% per year
Abo Wind AG
Start price
Target price
Perf. (%)
€59.80
27.11.21
27.11.21
-
27.11.22
27.11.22
0.33%
28.11.22
28.11.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
IVU Traffic Technologies AG
Start price
Target price
Perf. (%)
€20.05
27.11.21
27.11.21
-
27.11.22
27.11.22
-19.60%
28.11.22
28.11.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Encavis AG
Start price
Target price
Perf. (%)
€16.37
27.11.21
27.11.21
-
27.11.22
27.11.22
18.51%
28.11.22
28.11.22
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Undervalued
negative Cash Flow expected
Energiekontor
Start price
Target price
Perf. (%)
€75.50
27.11.21
27.11.21
-
27.11.22
27.11.22
17.22%
28.11.22
28.11.22
EBIT growth >5% per year expected
Fair valuation
High dividend yield expected
Good rating
STO SE & Co. KGaA
Start price
Target price
Perf. (%)
€201.00
27.11.21
27.11.21
-
27.11.22
27.11.22
-23.18%
28.11.22
28.11.22
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High dividend yield expected
Xiaomi Corp.
Start price
Target price
Perf. (%)
€2.16
27.11.21
27.11.21
€1.70
27.11.22
27.11.22
-3.19%
02.01.22
02.01.22
Growths faster than the competition
EBIT growth >5% per year expected
positive Cash Flow expected
Sustainability is little important
Umt United Mobility Tech. AG
Start price
Target price
Perf. (%)
€7.64
27.11.21
27.11.21
€7.00
27.11.22
27.11.22
16.23%
02.01.22
02.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Inovio Pharma
Start price
Target price
Perf. (%)
€6.45
27.11.21
27.11.21
€3.30
27.11.22
27.11.22
-52.69%
12.04.22
12.04.22
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Scanship Hldg ASA Nk -,10
Start price
Target price
Perf. (%)
€2.17
27.11.21
27.11.21
€1.40
27.11.22
27.11.22
1.75%
12.04.22
12.04.22
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
negative Cash Flow expected